Joshua R. Disbrow - Dec 21, 2022 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role: Chief Executive Officer, Director
Signature: /s/ Joshua R. Disbrow
Stock symbol: AYTU
Transactions as of: Dec 21, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/23/2022, 04:27 PM
Previous filing: Dec 21, 2022
Next filing: Jun 15, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AYTU	Common Stock	Disposed to Issuer	$0	-80K	-6.49%	$0.00	1.15M	Dec 20, 2022	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 21, 2022, the reporting person and the Issuer determined to rescind 80,000 vested shares of restricted common stock originally granted to the reporting person on April 16, 2021. The vesting of the remaining restricted shares remains unchanged with 1/12 vesting on the first day of each quarterly anniversary of the grant, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continued service with the Issuer.

Content

On December 21, 2022, the reporting person and the Issuer determined to rescind 80,000 vested shares of restricted common stock originally granted to the reporting person on April 16, 2021. The vesting of the remaining restricted shares remains unchanged with 1/12 vesting on the first day of each quarterly anniversary of the grant, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continued service with the Issuer.